Newborn screening test developed for rare, deadly neurological
Por um escritor misterioso
Descrição
A study led by Washington University School of Medicine in St. Louis describes a newborn screening test that identifies infants with Niemann-Pick type C, an often fatal condition in which cholesterol builds up and eventually destroys brain cells. Early detection may save lives and improve prospects for managing the disease.
Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study - The Lancet Neurology
Parents urge Oregon to test newborns for Krabbe disease
Screening Newborns For Disease Can Leave Families In Limbo : Shots - Health News : NPR
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy
Genomic newborn screening for rare diseases
Newborn screening undermined by hospital delays; babies put at risk
The complex aetiology of cerebral palsy
Parents push for standardized screening of Jewish genetic diseases
Achieving the Life-saving Potential of Newborn Screening - Ultragenyx
Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs - The Lancet Regional Health – Western Pacific
Updated: U.S. health secretary recommends newborn screening for fatal genetic disease, Science
Birth asphyxia: Causes, symptoms, and treatment
Understanding and Modernizing Newborn Screening - Rare Coalition
IJNS, Free Full-Text
Niemann Pick Disease Type C - Symptoms, Causes, Treatment
de
por adulto (o preço varia de acordo com o tamanho do grupo)